Filter by
NewsNew results showing LACIDOFIL® protects from early-life stress consequencesInfantile stress predisposes individuals to higher anxiety in adulthood. In a new in vivo study, early intake of Lacidofil® (Lallemand Health Solutions proprietary combination of L. rhamnosus Rosell®11 and L. helveticus Rosell®-52) prevented early-life stress consequences in rodents. This is the seventh study documenting various positive effects of this specific probiotic formula in early-life stress. […]
Nov 16, 2020
NewsCEREBIOME® capacity to increase brain-derived neurotrophic factor levels translates from preclinical to clinical studyA new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly brain-derived neurotrophic factor (BDNF) serum levels as observed several years ago in preclinical models. These new results bring more understanding about the potential modes of action of CEREBIOME® on the gut-brain axis, especially on depressive population. Previously, in 2018, Kazemi et al. followed […]
Oct 20, 2020
NewsThe first psychobiotic in BrazilApsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the brain-gut axis on the Brazilian market, with approved health claims by the Brazilian Health Authorities, ANVISA. Probid and Probians, produced by Lallemand Health Solutions, are available to the Brazilian market since September 2020. […]
Oct 13, 2020
NewsAll together “Running for research” to fund Prader-Willis syndrome researchLallemand Health Solutions is pleased to announce its partnership with Prader-Willi syndrome association (PWS) | USA, and “Running for Research,” a charitable initiative to raise funds for PWS research at the University of Florida. The next run will take place at the Walt Disney World Marathon from January 6 to 10, 2021. Since its founding in 2018, the “Running for Research” team […]
Sep 9, 2020
NewsMeet ROSELLA: A convenient orally administered probiotic shown to support women’s intimate healthLallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo on September 7 2020. L. plantarum P17630 (Proge P17630®), ROSELLA, licensed from PROGE FARM®, Italy, is a unique strain isolated from a healthy vaginal flora with full mechanistic and clinical evidence of efficacy […]
Sep 1, 2020
NewsLallemand Health Solutions close a major licensing deal with Proge Farm®Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization by Lallemand Health Solutions of Proge Farm®’s established probiotic strain L. plantarum P17630 (Proge P17630®), which has specific women health benefits. “Proge Farm® highly documented probiotic strain L. plantarum P17630 (Proge P17630®), is […]
Jul 17, 2020
NewsLallemand innovative probiotic yeast solutionsAs an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S. boulardii, a time tested yeast mastered and perfected from lab to shelf through a new website and instructive video. S. boulardii by LALLEMAND: CULTURES THAT MATTER Pioneer in formulating probiotic solutions, Lallemand Health […]
Jul 8, 2020
NewsIntroducing CEREBIOME®: Pioneering psychobiotic. Game-changing science.Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175. As pioneer and expert in research on the brain-gut axis, Lallemand Health Solutions launches a new informative hub cerebiomebylallemand.com regrouping a mine of facts and evidences on the power […]
Jun 17, 2020
NewsChina health authorities’ acknowledge L. helveticus Rosell®-52, B. infantis Rosell®-33 and B. bifidum Rosell®-71 for safe use in infant formulaLallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed the approval process by the National Health Commission of the People’s Republic of China for use in infant food. “This endorsement is a prodigious regulatory achievement given the limited number of strains that […]
Jun 8, 2020
NewsThe Lallemand group on track for finding a COVID-19 vaccineThe Lallemand group, in partnership with Biotechnologies Ulysse and Bio-K Plus, all Canadian companies, are joining forces to develop a vaccine against the COVID-19 pandemic. In a news report by journalist Frédéric Arnould broadcasted on Canadian national television last week, Yves Hurtubise president and researcher at Ulysse Biotech, also a doctor of biotechnology, applied microbiology, […]
May 11, 2020